- Open
- 5.60
- High
- 5.70
- Low
- 5.50
- Close
- 5.62
- Change
- +0.00 (0.00%)
- Volume
- 1,033,292
| 2 Oct 2026 | 07:00:03 | Notice of AGM, Directorate Changes & Annual Report |
| 16 Sept 2026 | 15:57:46 | Notice of Investor Webinar |
| 15 Sept 2026 | 11:36:34 | Director Share Purchase |
| 14 Sept 2026 | 12:38:34 | Director Share Purchase |
| 4 Nov 2024 | Annual Report and Accounts (to 2024-04-30) | |
| 3 Nov 2023 | Annual Report and Accounts (to 2023-04-30) | |
| 14 Oct 2022 | Annual Report and Accounts (to 2022-04-30) |
Kromek Group plc develops and manufactures radiation detection and bio-detection technology solutions, utilizing cadmium zinc telluride (CZT) and related technologies. The company operates in advanced imaging markets, including medical, security, and industrial sectors, providing OEM customers with detector components for applications such as disease detection and contamination monitoring. Kromek also offers nuclear radiation detection solutions for the homeland defense and security market, focusing on protecting critical infrastructure from threats. The company generates revenue primarily through the sale of radiation equipment and technology development. Kromek is headquartered in County Durham, UK, with manufacturing operations in both the UK and the US.
| 2 Oct 2026 | 07:00:03 | Notice of AGM, Directorate Changes & Annual Report |
| 16 Sept 2026 | 15:57:46 | Notice of Investor Webinar |
| 15 Sept 2026 | 11:36:34 | Director Share Purchase |
| 14 Sept 2026 | 12:38:34 | Director Share Purchase |
| 4 Nov 2024 | Annual Report and Accounts (to 2024-04-30) | |
| 3 Nov 2023 | Annual Report and Accounts (to 2023-04-30) | |
| 14 Oct 2022 | Annual Report and Accounts (to 2022-04-30) |
Kromek Group plc develops and manufactures radiation detection and bio-detection technology solutions, utilizing cadmium zinc telluride (CZT) and related technologies. The company operates in advanced imaging markets, including medical, security, and industrial sectors, providing OEM customers with detector components for applications such as disease detection and contamination monitoring. Kromek also offers nuclear radiation detection solutions for the homeland defense and security market, focusing on protecting critical infrastructure from threats. The company generates revenue primarily through the sale of radiation equipment and technology development. Kromek is headquartered in County Durham, UK, with manufacturing operations in both the UK and the US.
| 14 Sept 2026 |
| 07:00:09 |
| Final Results |
| 16 Sept 2025 |
| AIM moves: Focusrite improves revenues and Manolete Partners expects significant second half weighting |
| 14 Sept 2026 |
| 07:00:09 |
| Final Results |
| 16 Sept 2025 |
| AIM moves: Focusrite improves revenues and Manolete Partners expects significant second half weighting |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £375m | -0.5% | |
| £279m | -0.1% | |
KMKKromek Group plc | £37m | -0.1% |
| £5m | -0.8% | |
| £2m | -0.8% | |
| £889k | +0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £375m | -0.5% | |
| £279m | -0.1% | |
KMKKromek Group plc | £37m | -0.1% |
| £5m | -0.8% | |
| £2m | -0.8% | |
| £889k | +0.3% |